Navigation Links
Astellas Promotes Doug Geiger to Vice President, Head of New Therapeutic Areas in Marketing Strategy
Date:10/27/2015

NORTHBROOK, Ill., Oct. 27, 2015 /PRNewswire/ -- Astellas recently announced that Doug Geiger has been promoted to the position of vice president, head of New Therapeutic Areas in Marketing Strategy. Geiger will be responsible for delivering global strategic commercial leadership on key initiatives within Astellas' emerging therapeutic areas. He will report to Yukio Matsui, senior vice president and head of Marketing Strategy.

"Doug has been a pivotal strategic commercial leader since joining Astellas in 2008," said Matsui. "He will play an instrumental role as we establish a presence in new therapeutic focus areas such as pain, central nervous system, nephrology and inflammation."

Geiger brings 23 years of experience in the pharmaceutical industry. He joined Astellas in 2008 as director of New Product Planning in the U.S., and helped establish the oncology business unit. Since 2012, Geiger has served as senior director and head of the New Product Planning in the U.S., where he played a vital role in optimizing the commercial potential of Astellas' pipeline.

Prior to Astellas, Geiger held several commercial leadership positions at Abbott Laboratories and TAP Pharmaceuticals in marketing, commercial strategy and global commercial development. 

Geiger earned his Bachelor of Science in finance from the University of Illinois, holds a Master of Science in accounting from DePaul University Kellstadt Graduate School of Business and a Masters in Business Administration from Northwestern University Kellogg School of Management.  

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable pharmaceuticals. For more information on Astellas, please visit our website at www.astellas.us, follow us on Twitter at www.twitter.com/AstellasUS or like our Facebook page at www.facebook.com/AstellasUS.

Photo - http://photos.prnewswire.com/prnh/20151027/281191
Logo - http://photos.prnewswire.com/prnh/20140416/84970

 


'/>"/>
SOURCE Astellas
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Astellas and Chromocell Announce License and Collaboration Agreement to Develop and Commercialize New Therapies to Treat Neuropathic Pain
2. Astellas European Foundation gewährt Zuschüsse zur Untersuchung neuartiger molekularer Bildgebungstechniken für Patienten mit Prostatakrebs
3. Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections
4. Julie Monzo Joins Astellas Corporate Affairs
5. Astellas And Medivation Announce Enrollment Of The First Patients In Advanced Prostate Cancer Outcomes Registry
6. Astellas and The Chris Klug Foundation Announce Winners of the 2015 Bounce Back Award
7. Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML)
8. Astellas Pharma EMEA Celebrates Its 10th Anniversary
9. Astellas honors 10 years of patient care and community involvement with Changing Tomorrow Day service activities
10. Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting
11. Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... struggle women face in her book, Miracle Baby: A Fertility Doctor’s Fight for ... board-certified OB-GYN and fertility specialist, Noorhasan writes to educate, encourage, advise and support ...
(Date:10/8/2019)... TORONTO (PRWEB) , ... October 08, 2019 , ... ... oral delivery of lipid formulations which includes both soft elastic capsules and liquid ... of these technologies can provide formulators with effective delivery platforms during early-phase development ...
(Date:10/8/2019)... ... October 08, 2019 , ... ChoiceSpine LLC, a privately-held spinal device ... the company’s expertise, deepen its knowledge base, and drive sales growth. , The following ... KC Gilbert promoted to Senior Vice President of Strategic Partnerships; ...
Breaking Medicine Technology:
(Date:10/15/2019)... ... 2019 , ... An October 3 article on CNN Health explains ... points out that both agents are mildly abrasive; so while they may be good ... toothpastes, they are also good at stripping the enamel off of teeth if used ...
(Date:10/15/2019)... ... October 15, 2019 , ... In 2019, Unitek opened its doors to various ... late 2018 . Students who started in July were only entering their second term ... students would have to start over. Then the leadership team at Unitek honored their ...
(Date:10/15/2019)... ... October 15, 2019 , ... Nashville Fertility Center (NFC) is proud to ... to join the practice. In addition to treating general infertility, Dr. Van Heertum offers ... at NFC looks forward to Dr. Van Heertum joining the practice and believes she ...
(Date:10/11/2019)... ... October 11, 2019 , ... Inland Detox, Inc. has just moved ... location has incredible views of the Temecula Valley and it’s the perfect place for ... facility offers both private rooms as well as double occupancy rooms, a 2nd home ...
(Date:10/10/2019)... ... , ... AltMed Florida , one of the fastest growing Medical Marijuana ... opening of its second MÜV™ Medical Cannabis Dispensary on the First Coast – scheduled ... Beach. , Located at Beach Plaza Shopping Center at the corner of Beach Boulevard ...
Breaking Medicine News(10 mins):